Cargando…

Emerging computational paradigms to address the complex role of gut microbial metabolism in cardiovascular diseases

The human gut microbiota and its associated perturbations are implicated in a variety of cardiovascular diseases (CVDs). There is evidence that the structure and metabolic composition of the gut microbiome and some of its metabolites have mechanistic associations with several CVDs. Nevertheless, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aminian-Dehkordi, Javad, Valiei, Amin, Mofrad, Mohammad R. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589059/ https://www.ncbi.nlm.nih.gov/pubmed/36299869 http://dx.doi.org/10.3389/fcvm.2022.987104

Ejemplares similares

Gut-on-a-chip models for dissecting the gut microbiology and physiology
por: Valiei, Amin, et al.
Publicado: (2023)

Role of Biological Sex in the Cardiovascular-Gut Microbiome Axis
por: Li, Shuangyue, et al.
Publicado: (2022)

Molecular and Integrative Physiological Effects of Isoflurane Anesthesia: The Paradigm of Cardiovascular Studies in Rodents using Magnetic Resonance Imaging
por: Constantinides, Christakis, et al.
Publicado: (2016)

Clinical practice guidelines for cardiovascular disease: how is depression addressed? Protocol for a systematic review
por: Blatch Armon, Dana, et al.
Publicado: (2023)

The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases
por: Ionescu, Ruxandra Florentina, et al.
Publicado: (2022)

Implementation of a virtual international cardiology curriculum to address the deficit of cardiovascular education in Haiti: a pilot study
por: Haynes, Norrisa Adrianna, et al.
Publicado: (2021)

Gut immune cells—A novel therapeutical target for cardiovascular disease?
por: Ganesh, Naresh, et al.
Publicado: (2022)

Systems Medicine as an Emerging Tool for Cardiovascular Genetics
por: Haase, Tina, et al.
Publicado: (2016)

Obesity and Cardiovascular Disease: The Emerging Role of Inflammation
por: Khafagy, Rana, et al.
Publicado: (2021)

Cancer and Thrombotic Risk: The Platelet Paradigm
por: Lee, Elizabeth C., et al.
Publicado: (2017)

Editorial: Emerging roles of miRNAs in cardiovascular disease
por: Santovito, Donato, et al.
Publicado: (2023)

Causal associations between gut microbiome and cardiovascular disease: A Mendelian randomization study
por: Zhang, Yuxuan, et al.
Publicado: (2022)

Editorial: Gut permeability-related endotoxemia and cardiovascular disease: A new clinical challenge
por: Violi, Francesco, et al.
Publicado: (2023)

The Burden of Ventricular Premature Complex Is Associated With Cardiovascular Mortality
por: Lee, Po-Tseng, et al.
Publicado: (2022)

The emerging role of estrogen's non-nuclear signaling in the cardiovascular disease
por: Tokiwa, Hiroyuki, et al.
Publicado: (2023)

A computational study of aortic insufficiency in patients supported with continuous flow left ventricular assist devices: Is it time for a paradigm shift in management?
por: Grinstein, Jonathan, et al.
Publicado: (2022)

Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites
por: Vijay, Amrita, et al.
Publicado: (2021)

Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model
por: Langlo, Knut Asbjørn Rise, et al.
Publicado: (2021)

Increasing use of systems science in cardiovascular disease prevention to understand how to address geographic health disparities in communities with a disproportionate burden of risk
por: Bauer, Kyla L., et al.
Publicado: (2023)

Editorial: Conduction system pacing: What’s missing for the paradigm shift?
por: Marcantoni, Lina, et al.
Publicado: (2023)

Potential of four definitions of metabolic syndrome to discriminate individuals with different 10-year cardiovascular disease risk scores: a cross-sectional analysis of an Iranian cohort
por: Zibaeenezhad, Mohammad Javad, et al.
Publicado: (2022)

Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
por: Aday, Aaron W., et al.
Publicado: (2019)

Beat-Level Interpretation of Intra-Patient Paradigm Based on Object Detection
por: Kang, Man, et al.
Publicado: (2022)

Hypertension and human immunodeficiency virus: A paradigm for epithelial sodium channels?
por: Mutengo, Katongo H., et al.
Publicado: (2022)

Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside
por: Nebigil, Canan G., et al.
Publicado: (2020)

Lung-Centered Open Heart Surgery: A Call for a Paradigm Change
por: Gologorsky, Edward, et al.
Publicado: (2016)

Editorial: Decoding complexity: new insights into the cellular and molecular mechanisms of cardiovascular and metabolic diseases
por: Liu, Chia-Feng, et al.
Publicado: (2023)

Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1
por: Ghai, Shruti, et al.
Publicado: (2023)

Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy
por: Quarta, C. Cristina, et al.
Publicado: (2022)

Machine learning-based detection of cardiovascular disease using ECG signals: performance vs. complexity
por: Pham, Huy, et al.
Publicado: (2023)

Analysing cardiovascular risk factors and related outcomes in a middle-aged to older adults population in Iran: a cohort protocol of the Shiraz Heart Study (SHS)
por: Zibaeenezhad, Mohammad Javad, et al.
Publicado: (2019)

The Emerging Role of Rho Guanine Nucleotide Exchange Factors in Cardiovascular Disorders: Insights Into Atherosclerosis: A Mini Review
por: Li, Mengqi, et al.
Publicado: (2022)

Urgent and emergent repair of complex aortic aneurysms using an off-the-shelf branched device
por: Nana, Petroula, et al.
Publicado: (2023)

Evidence for the Benefits of Melatonin in Cardiovascular Disease
por: Tobeiha, Mohammad, et al.
Publicado: (2022)

ULTrasound-guided TRAnsfemoral puncture in COmplex Large bORe PCI: study protocol of the UltraCOLOR trial
por: Meijers, Thomas A, et al.
Publicado: (2022)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
por: Masbuchin, Ainun Nizar, et al.
Publicado: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
por: Hu, Xiaomin, et al.
Publicado: (2022)

Role of Cardiovascular Computed Tomography in Acute Coronary Syndromes During the COVID-19 Pandemic-Single Center Snapshot Study
por: Alasnag, Mirvat, et al.
Publicado: (2021)

Commentary: Plaque Features and Epicardial Fat Volume for Cardiovascular Risk Assessment—A Key Role With Cardiac Computed Tomography?
por: Tesche, Christian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tcf2jb7ek80ji9qm50hs8mvt9s